Enhanced plant regeneration and transformation by use of GRF1-enhancing genes

By introducing GRF1 polypeptide or its coding sequence into plant cells, the plant regeneration ability is improved, and the problem of low conversion efficiency in the prior art is solved, and more efficient recovery and regeneration of transgenic plants is achieved.

CN119040377APending Publication Date: 2024-11-29KWS SAAT SE & CO KGAA
View PDF 11 Cites 0 Cited by

Patent Information

Application Number
CN202410979615.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2019-06-28
Filing Date
2020-06-29
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

In the existing plant gene editing technology, the regeneration ability of plant cells after transformation and genetic modification is limited, resulting in low transformation efficiency and unsuitable for a variety of plant species. Commonly used tools such as the CRISPR system are limited in plant biotechnology.

Method used

By introducing GRF1 polypeptide or its encoded nucleotide sequence, the regeneration ability of plant cells is promoted, and the co-expression or transient co-expression of GRF1 and target genes are used to improve the recovery efficiency of transgenic plants, and the regeneration ability of plants is improved through genome editing technology .

Benefits of technology

It significantly improves transformation and regeneration efficiency, reduces the recovery time of genetically modified plants, produces healthy plants and no obvious phenotype, and is suitable for a variety of plant species.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The present invention relates to the field of plant breeding and biotechnology, in particular to the production of plants from cells and other tissues. More specifically, the present invention provides methods and tools for improving plant regeneration, particularly from transformed or genetically modified plant cells using GRF1-enhanced genes.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of a patent application with an application date of June 29, 2020, application number 202080056958.6, and invention name “Enhanced plant regeneration and transformation achieved by using GRF1 enhancing gene”.

[0002] The present invention relates to the field of plant breeding and biotechnology, and in particular to the production of plants from cells and other tissues. More specifically, the present invention provides methods and tools for improving plant regeneration, in particular from transformed or genetically modified plant cells.

[0003] In plant breeding, the process of manipulating plant species in order to form the desired genotype and phenotype for specific purposes has been practiced since close to the beginning of human civilization. This agricultural field has undergone major changes in recent decades with the development of genetic engineering. Various methods have been developed for plant genetic engineering. The choice of transformation method depends on many variables, mainly the plant species to be transformed, the purpose of the experiment and the availability of the necessary equipment. Most plant transformation techniques require the use of explants with high regeneration capacity as starting material. In addition, gene editing constitutes a new molecular biological method by which specific modifications such as insertions, deletions or point mutations or combinations thereof can be introduced into the genome of plants. For this purpose, specific molecular tools are required, which firstly have nuclease activity, but most importantly can be guided to the target sequence to be modified with sufficient specificity to program and perform specific site-directed mutagenesis. In the past few years, in plant biotechnology, specific genome editing has developed as an alternative to conventional breeding as well as transgenic strategies. However, currently available tools, such as meganucleases, zinc finger nucleases (ZFNs), "transcription activator-like effector nucleases" (TALENs) or CRISPR systems, are used in plant biotechnology only to a limited extent due to the limited regeneration capacity of plants from edited starting material.

[0004] A variety of cells have the potential to develop into embryos, including haploid gametophytic cells, such as cells of pollen and embryo sac (see Forster, BP et al. (2007) Trends Plant Sci. 12:368-375 and Seguí-Simarro, JM (2010) Bot. Rev. 76:377-404) and somatic cells derived from all three basic tissue layers of plants (Gaj, MD (2004) Plant Growth Regul. 43:27-47 or Rose, R. et al. (2010) "Developmental biology of somatic embryogenesis" in Plant Developmental Biology-Biotechnological Perspectives, Pua EC and Davey MR eds. (Berlin Heidelberg: Springer), pp. 3-26).

[0005] The ability to regenerate into plants is usually limited to specific genotypes in certain plant species and is weakened in transformed and genetically modified plant cells and other precursor tissues. Even if the transformation and genetic modification steps of plant cells are successful, this does not necessarily mean that the desired plants can actually be obtained from the modified cells. It is assumed that the treatments to which plant cells and other precursor tissues are subjected in order to achieve genetic modification affect plant development and regeneration. Therefore, the object of the present invention is to improve the efficacy of previously known methods for producing transgenic and genetically modified plants, and to support the regeneration of plants from modified plant cells and other plant precursors.

[0006] Lowe K et al. (2016, "Morphogenic regulators Baby boom and Wuschel improve monocot transformation" Plant Cell 28: 1998-2015.) reported a transformation method that uses morphogenic genes to generate a biological background that contributes to transformation efficiency. Their transformation constructs include corn (maize) Baby boom (BBM) and Wuschel2 (WUS2). The authors used these constructs for Agrobacterium-mediated transformation of immature embryos from four maize inbred lines. These lines showed significantly higher transformation rates, from 0% to 2% in the control to 25% to 51% in the presence of WUS2 and BBM. However, this method has disadvantages and is generally not applicable because plants constitutively expressing ZmWUS2 and ZmBBM are generally sterile or even lethal. Therefore, it is desirable to have a method for improving transformation and regeneration efficiency that results in plants that do not display a recognizable phenotype.

[0007] In van der Knaap et al. (2000; "A novel gibberellin-induced gene from rice and its potential regulatory role in stem growth", Plant physiology, 122(3), 695-704.), the authors have identified and characterized the first member of the GRF gene family in rice (OsGRF1). This is a gibberellic acid-induced gene in the intercalary meristem. Overexpression in Arabidopsis leads to impaired stem growth, female sterility, and reduced male fertility. Application of gibberellic acid was unable to restore the stem elongation defect of the transformed plants, indicating that OsGRF1 may be involved in GA-induced stem elongation. In 2003, Kim et al. ("The AtGRF family of putative transcription factors is involved in leaf and cotyledon growth inArabidopsis", The Plant Journal, 36(1), 94-104.) characterized the Arabidopsis GRF family and determined that the genes are primarily expressed in actively growing tissues. Analysis of null mutants and transgenic plants overexpressing AtGRF1 and AtGRF2 showed that some members of the GRF family are involved in the regulation of cell expansion during leaf and cotyledon growth. In addition, overexpressing plants showed delayed bolting time, revealing a putative role in flowering. In a study to determine the molecular mechanisms that coordinate cell proliferation in developing leaves, Rodriguez et al. found that miR396 antagonizes the expression pattern of its target GRF transcription factor in Arabidopsis ((2010), "Control of cell proliferation in Arabidopsisthaliana by microRNAmiR396", Development, 137(1), 103-112.). Therefore, the balance between miR396 and GRF controls the final number of cells in the leaf. In addition, the authors showed that GRF targeted by miR396 can regulate the size of the shoot apical meristem.

[0008] Kuijt et al. (2014, "Interaction between the GROWTH-REGULATING FACTOR and KNOTTED1-LIKE HOMEOBOX Families of Transcription Factors", Plantphysiology, 164 (4), 1952-1966.) showed that members of the GRF family act as participants in a network that controls the expression of KNOTTED1-LIKE HOMEBOX (KNOX) genes involved in the restriction of cell differentiation in the shoot apical meristem. AtGRF4, AtGRF1 and AtGRF6 are able to bind to the promoter of KNOX genes, thereby inhibiting their expression. Arabidopsis seedlings overexpressing AtGRF4, AtGRF1 or AtGRF6 exhibit developmental abnormalities in the shoot apical meristem.

[0009] Nelissen H et al. (2015, "Dynamic Changes in ANGUSTIFOLIA3 Complex Composition Reveal Growth Regulatory Mechanism in the Maize Leaf.", Plant Cell 287:1605-1619.) described the function of ZmGRF1 during maize leaf development.

[0010] In summary, several GRF genes are known to play a role in leaf morphogenesis and stem development. In addition, GRF genes have been reported to play a role in flowering, seed and root development, control plant growth under stress conditions and regulate plant lifespan.

[0011] However, in their research, the inventors of the present invention surprisingly discovered another new function of GRF1 (GRF1). GRF1 can provide a positive effect of promoting plant regeneration, and thus allow transgenic plants to recover more effectively. The present invention allows for improved regeneration from different tissues or cells (e.g., microspores), can overcome resistance to plant regeneration, particularly genotype dependence, improve the recovery of transgenic plants by, for example, co-expression of a target gene with GRF1, and improve the recovery of genome-engineered plants by, for example, transient co-expression of a genome editing component with GRF1, and shorten the time to generate transgenic lines and recovery. Further, it was found that plants carrying GRF1 were healthy and did not show any obvious phenotype. Therefore, a first aspect of the present invention is the use of a GRF1 polypeptide for improving the regeneration ability of a plant.

[0012] Any reference hereinafter to a polypeptide or protein useful in the methods of the invention refers to a GRF1 polypeptide or GRF1 protein as defined herein. Any reference hereinafter to a nucleic acid or polynucleotide useful in the methods of the invention (except for the nucleotide sequence of interest to be transformed or the nucleic acid molecule optionally used as a repair template for modifying the genome of a plant) refers to a nucleic acid or polynucleotide capable of encoding such a GRF1 polypeptide or GRF1 protein. In one embodiment, any reference to a polypeptide / protein or nucleic acid / polynucleotide useful in the methods of the invention is understood to refer to a protein or nucleic acid useful in the methods of the invention, constructs, expression cassettes, plant cells, plants, seeds, harvestable parts and products. The nucleic acid / polynucleotide, including mRNA, to be introduced into a plant cell or plant (and thus useful for performing the methods of the invention) is any nucleic acid / polynucleotide encoding a polypeptide / protein type that will now be described, hereinafter also referred to as "GRF1 nucleic acid", "GRF1 polynucleotide", "GRF1 gene" or "GRF1 mRNA" etc.

[0013] As defined herein, "GRF1 polypeptide" or "GRF1 protein" refers to a transcription factor, preferably the 14-3-3-like protein GF14-6, more preferably comprising the PFAM domain PF08880 (also known as the QLQ domain) and the PFAM domain PF08879 (also known as the WRC domain), and even more preferably comprising at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 100%, at least 101%, at least 102%, at least 103%, at least 104%, at least 105%, at least 106%, at least 107%, at least 108%, at least 109%, at least 110%, at least 111%, at least 112%, at least 113%, at least 114%, at least 115%, at least 116%, at least 117%, at least 118%, at least 119%, at least 120%, at least 121%, at least 122%, at least 123%, at least 124%, at least 125%, at least 126%, at least 127%, at least 128%, at least 129%, at least 130%, at least 131%, at least 132%, at least 133%, at least 134%, at least 135%, at least 136%, at least 137%, at least 138%, at least 139%, at least 140%, at least 141%, at least 142%, at least 143%, at least 144%, at least 145%, at least 146%, at least 147%, at least 148%, at least 149%, at least 15 Preferably, at least one of the matches has a coverage of at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100%. Preferably, at least one of the matches has a coverage of at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100%. Preferably, at least one of the matches has a coverage of at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100%. Preferably, at least one of the matches has a coverage of at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100%. Preferably, at least one of the matches has a coverage of at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100%. Preferably, at least one of the matches has a coverage of at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100%. Preferably, at least one of the matches has a coverage of at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100%. Preferably, at least one of the matches has a coverage of at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100%.

[0014] In one embodiment, both matching stretches of amino acids are located in the N-terminal half of the GRF1 polypeptide, preferably, the stretch of amino acids matching PFAM domain PF08880 is located in the N-terminal quarter of the GRF1 polypeptide. Preferably, PFAM domain PF08880 matches amino acid residues of the GRF1 polypeptide starting from residue 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 or 25 of the GRF1 polypeptide, preferably from residue 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or 21, and PFAM domain PF08879 matches amino acid residues of the GRF1 polypeptide starting from residue 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 100, 100, 100, 100, 100, 100, 100 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99, preferably starting from residue 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94 or 95. Preferably, the distance between the starting amino acid residue of the amino acid segment matching the PFAM domain PF08880 and the starting amino acid residue of the amino acid segment matching the PFAM domain PF08879 is 60 to 82 amino acids within the GRF1 polypeptide, more preferably 60 to 75 amino acids, more preferably 61 to 75 amino acids, and even more preferably 62 to 73 amino acids within the GRF1 polypeptide.

[0015] In another embodiment, a GRF1 polypeptide as used herein comprises the indicated motif: [D]-[P]-[E]-[P]-[G]-[R]-[C]-[R]-[R]-[T]-[D]-[G]-[K]-[K]-[W]-[R]-[C]-[AS]-[RK]-[ED]-[A]-[AH]-[PQS]-[D]-[S]-[K]-[Y]-[C]-[E]-[KR]-[H]-[M]-[H]-[R]-[G]-[R]-[N]-[R] (SEQ ID NO:25), wherein it is permissible / tolerable that the GRF1 polypeptide exhibits a maximum number of two mismatches compared to the indicated motif (i.e., at most two mismatches may occur in the sequence comparison between the corresponding GRF1 polypeptide and the indicated motif), preferably exhibits a maximum number of one mismatch compared to the indicated motif (i.e., only one mismatch may occur in the sequence comparison between the corresponding GRF1 polypeptide and the indicated motif), and more preferably has no mismatches compared to the indicated motif. A mismatch refers to a substitution of an amino acid at a certain position according to the indicated motif by a different amino acid, or a deletion or displacement by the insertion of at least one additional amino acid. The letters of the motif indicated in square brackets represent amino acid residues (single-letter code), and the motif represents the order of amino acid residues in the direction from the N-terminus to the C-terminus as present in any GRF1 polypeptide of the present invention. If two or three letters are present in one square bracket, they represent alternatives. The motif has been deduced from a comprehensive comparison of sequences of GRF1 polypeptides derived from different plant species, including monocots as well as dicots, and allows to distinguish GRF1 polypeptides from other members of the GRF protein family, such as GRF5. Preferably, the motif is located in the N-terminal half of the GRF1 polypeptide, more preferably, the motif is located in the N-terminal half of the GRF1 polypeptide and comprises a subregion of the amino acid stretch matching the PFAM domain PF08879, i.e. the motif has a sequence overlap with the amino acid stretch matching the PFAM domain PF08879. Preferably, the indicator motif consists of any one of the amino acid sequences SEQ ID NO: 26 to SEQ ID NO: 35. Correspondingly, the GRF1 polypeptide preferably comprises one continuous motif consisting of any one of the amino acid sequences SEQ ID NO: 26 to SEQ ID NO: 35.

[0016] According to one aspect, the present invention provides a method for transforming plant cells, the method comprising the following steps:

[0017] (a1) Introduction into plant cells

[0018] (i) at least one nucleotide sequence of interest; and

[0019] (ii) an expression cassette comprising a polynucleotide encoding a GRF1 polypeptide, an mRNA encoding a GRF1 polypeptide, or a GRF1 polypeptide, wherein (i) and (ii) may be introduced simultaneously or sequentially in any order, or

[0020] (a2) introducing at least one nucleotide sequence of interest into a plant cell; and inducing in parallel or sequentially an enhanced expression level of an endogenous gene encoding a GRF1 polypeptide in the plant cell; and

[0021] (b) optionally cultivating the plant cell of (a1) or (a2) or a plant cell derived from the plant cell of (a1) or (a2) under the following conditions, wherein in the plant cell, the GRF1 polypeptide is expressed from the expression cassette, the GRF1 polypeptide is translated from the introduced mRNA, the GRF1 polypeptide is enhanced / increased in expression from the endogenous gene, or preferably, the GRF1 polypeptide is present in an increased amount compared to the amount in a wild-type plant cell or a plant cell into which a polynucleotide encoding a GRF1 polypeptide, an mRNA encoding a GRF1 polypeptide or an expression cassette of a GRF1 polypeptide has not been introduced according to step (a1) or into which an enhanced expression level of an endogenous gene encoding a GRF1 polypeptide has not been induced according to step (a2).

[0022] The method according to the invention produces a modified or transformed plant cell having improved regeneration capacity due to the presence of GRF1 or the presence of increased amounts of GRF1. However, it is preferred that the presence of GRF1 or the presence of increased amounts of GRF1 in the modified plant cell is transient.

[0023] Transformation of plant cells refers to the introduction of nucleic acid molecules into plant cells in a manner that results in stable integration into the plant cell genome or transient appearance in the plant cell, resulting in the expression of nucleic acid sequences that are, for example, constitutively, transiently or specifically associated with a particular tissue or certain developmental stages, etc. Transformation and regeneration of monocotyledonous and dicotyledonous plant cells are now routine, and the choice of the most appropriate transformation technique will be determined by the practitioner. The choice of method will vary with the type or genotype of the plant to be transformed; those skilled in the art will recognize the suitability of a particular method for a given plant type or genotype. Suitable methods may include, but are not limited to: electroporation of plant protoplasts; liposome-mediated transformation; polyethylene glycol (PEG)-mediated transformation; transformation using viruses; microinjection of plant cells; microprojectile bombardment of plant cells; vacuum infiltration; and Agrobacterium-mediated transformation.

[0024] Any suitable method known in the art can be used to perform the step (a1) (i) or (a2) of introducing the at least one nucleotide sequence of interest. Many methods can be used to transfer the target nucleic acid into a plant cell. An exemplary vector-mediated method is agrobacterium-mediated transformation, such as, for example, by Lindsay & Gallois, 1990, Journal of experimental botany and Kischenko et al., 2005, Cell biology international for sugarbeet, Ishida et al., 2007, for corn ("Agrobacterium-mediated transformation of corn. (Agrobacterium-mediated transformation of maize.) "Nature protocols, 2 (7), 1614-1621), or by the PureWheat Technology for wheat from Japan Tobacco Co., Ltd. as described. Other suitable techniques include particle bombardment and electroporation.

[0025] The nucleotide sequence of interest according to the present invention can be a DNA or RNA sequence, such as mRNA, siRNA, miRNA, etc. More specifically, the nucleotide sequence of interest encodes at least one phenotypic trait. Preferably, the phenotypic trait conferred by DNA or RNA can be selected from the following phenotypic traits: resistance / tolerance to biotic stress, including resistance / tolerance to pathogens, wherein the pathogens can be viruses, bacteria, fungi or animal pathogens; resistance / tolerance to abiotic stress, including cold resistance / tolerance, drought stress resistance / tolerance, osmotic resistance / tolerance, heat stress resistance / tolerance, cold or frost stress resistance / tolerance, oxidative stress resistance / tolerance, heavy metal stress resistance / tolerance, salt stress or flooding resistance / tolerance, lodging resistance / tolerance, seed falling resistance / tolerance, or resistance / tolerance to one or more herbicides (such as glyphosate, glufosinate, 2,4-D, dicamba, ALS inhibitors, etc.). The at least one phenotypic trait of interest may also be selected from the following phenotypic traits: modification of another agronomic trait of interest, including yield increase, flowering time modification, seed color modification, endosperm composition modification, nutrient content modification, or metabolic engineering of a pathway of interest.

[0026] In the context of the present invention, GRF1 can be introduced as an expression cassette comprising a polynucleotide encoding a GRF1 polypeptide, as an mRNA (also including pre-mRNA or precursor mRNA) encoding a GRF1 polypeptide, or as a GRF1 polypeptide. Exemplary techniques for introducing nucleic acid molecules are described above. Alternatively, GRF1 can be provided in plant cells by activating the expression of an endogenous gene encoding a GRF1 polypeptide. This will result in an enhanced expression level of the endogenous GRF1 gene, i.e., the GRF1 polypeptide is present or appears in the plant cell in an increased amount. Activation of endogenous gene expression can be achieved by modifying the activity or structure of the promoter of the endogenous gene encoding the GRF1 polypeptide. For example, enhancer elements can be introduced into the promoter by gene editing; or enhancer elements that regulate the promoter can be further strengthened, or silencer elements that regulate the promoter can be weakened by, for example, targeted mutagenesis / modification; or modifications can be introduced into the epigenome associated with the enhancer by gene editing tools such as the CRISPR system (Hilton et al. (2015)). Epigenomic editing by CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nature biotechnology, 33 (5), 510-517); or synthetic transcription factors based on, for example, TALE activators or dCas9 activators can be introduced into cells, where they are able to bind to targeted recognition sites on or near the promoter and activate transcription of the GRF1 gene (Cheng et al., (2013). Multiple activation of endogenous genes by RNA-guided transcription activator system CRISPR-on, Cell research, 23 (10), 1163.); or the amount of microRNA (miRNA) that regulates GRF1 gene expression by post-transcriptional inhibition in plant cells can be reduced by, for example, knockout (null mutant) or knockdown, so as to increase the amount of translated GRF1 polypeptide in plant cells.

[0027] Depending on the plant species and cell type, different levels of gene or expression activation are required so that sufficient amounts of GRF1 polypeptide are present in the plant cells when regeneration occurs. A person skilled in the art can use various techniques to measure the actual expression level of endogenous or introduced genes, such as qPCR, RT-PCR, Northern blot or microarray. These methods allow a person skilled in the art to adjust the expression level of the GRF1 gene by routine work, which improves the regeneration capacity of different tissues or somatic cells and reproductive cells (e.g., microspores). In a preferred embodiment, in a plant cell, the expression level of the endogenous gene encoding the GRF1 polypeptide is increased by at least 2 times, 3 times or 5 times, preferably 10 times, 25 times or 50 times, more preferably 100 times, 200 times or 500 times.

[0028] As further described above, the induction of the enhanced expression level of endogenous genes in plant cells can be carried out by applying one or more activators or their precursors. These can be applied to the culture medium in which the plant cells are cultured and then actively or passively absorbed by the plant cells. In addition, the one or more activators or their precursors can be directly introduced into the plant cells by microinjection, electroporation or gene gun bombardment. In addition to the above-mentioned synthetic transcriptional activators, many other activators are known according to the current development status of the art, which can be used to increase the expression level of endogenous genes, particularly the expression level of the endogenous GRF1 gene: In recent years, the technical fields of chemical plant genetics and chemical plant biology have emerged, in which biological systems are treated with small molecules to specifically interfere with cell functions. Small molecules are used commercially as drugs, herbicides and fungicides in different systems, but in recent years they have also been increasingly used as tools for genetic regulation. For example, chemical genetics involves the discovery of small molecule effectors of various cellular functions by screening compound libraries (Dejonghe & Russinova (2017). Plant Chemical Genetics: From Phenotype-Based Screens to Synthetic Biology. Plant Physiology, pp-01805; Kawasumi, M., & Nghiem, P. (2007). Chemical genetics: elucidating biological systems with small-molecule compounds. Journal of Investigative Dermatology, 127(7), 1577-1584.). Such small molecule effectors suitable for activating the expression of target genes such as GRF1 can be identified by chemical screening following different strategies (Dejonghe & Russinova, 2017). Comprehensive compound libraries are available that allow simple screening of numerous small molecules and identification of effectors that can be used to activate gene expression of genes such as GRF1. As mentioned above, another way to enhance the expression level of endogenous genes such as GRF1 is to apply so-called synthetic transcriptional activators. They are usually designed by fusion of a recognition domain with at least one activator domain. The recognition domain can be derived from known systems such as zinc fingers, TAL effectors or CRISPR; for activation, for example, fusion of the herpes simplex virus-derived VP-16 or VP-64 activation domain with the recognition domain can cause increased transcription. Weaker activation domains such as AD of human NF-κB increase the variety of options for gene activation.In addition, as shown for endogenous promoters, combinations of activators can be used to introduce synergistic effects (Moore et al. (2014). "Transcription activator-like effectors: a toolkit for synthetic biology." ACS synthetic biology, 3 (10), 708-716.; US2002 / 0046419 A1; Lowder et al. (2017). "Multiplexed transcriptional activation or repression in plants using CRISPR-dCas9-based systems." Plant Gene Regulatory Networks: Methods and Protocols, 167-184.). Synthetic transcription activators can also be delivered to plant cells or introduced into plant cells as precursors, i.e., as DNA or RNA molecules encoding such artificial or synthetic transcription activators or their domains, or as inactive forms of transcription activators that are later activated in the cell or in a specific compartment of the cell. Finally, enhancement of GRF gene expression can also be achieved by inactivation of upstream negative regulators or by generating mutant forms of the GRF1 gene that are resistant to such negative regulators.

[0029] Preferably, the GRF1 polypeptide of the present invention comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 2, 37, 39, 41, 43, 45, 47, 49, 51 and 53, or an amino acid sequence having at least 70% identity with a sequence selected from the group consisting of SEQ ID NO: 2, 37, 39, 41, 43, 45, 47, 49, 51 and 53, preferably an amino acid sequence having at least 80%, at least 85%, at least 90%, more preferably at least 95%, at least 98% or at least 99% identity with a sequence selected from the group consisting of SEQ ID NO: 2, 37, 39, 41, 43, 45, 47, 49, 51 and 53.

[0030] The exogenous (heterologous) or endogenous polynucleotide encoding the GRF1 polypeptide of the present invention comprises:

[0031] (i) an encoding nucleotide sequence selected from SEQ ID NO: 1, 36, 38, 40, 42, 44, 46, 48, 50 and 52;

[0032] (ii) a coding nucleotide sequence comprising a sequence that is at least 70%, preferably at least 80%, at least 85%, at least 90%, more preferably at least 95%, at least 98% or at least 99% identical to a nucleotide sequence selected from the group consisting of SEQ ID NO: 1, 36, 38, 40, 42, 44, 46, 48, 50 and 52;

[0033] (iii) a nucleotide sequence encoding a GRF1 polypeptide as defined above or a nucleotide sequence encoding a polypeptide encoded by (i) and / or (ii) within the degeneracy of the genetic code;

[0034] (iv) a nucleotide sequence complementary to the nucleotide sequence of (i), (ii) or (iii); or / and

[0035] (v) A nucleotide sequence that hybridizes to the nucleotide sequence of (iv) under stringent conditions.

[0036] Preferably, the polynucleotide encoding the GRF1 polypeptide, in particular the polynucleotide encoding the GRF1 polypeptide, may comprise the coding nucleotide sequence of SEQ ID NO:1.

[0037] For the purposes of the present invention, the "sequence identity" of two related nucleotide or amino acid sequences expressed as a percentage refers to the number of positions with identical residues (×100) in the two best aligned sequences divided by the number of positions compared. Gaps, i.e. positions where residues are present in one sequence and not in the other sequence in the alignment, are considered to be positions with different residues. The alignment of these two sequences is performed by the Needleman and Wunsch algorithms (Needleman and Wunsch 1970). The above-mentioned computer-assisted sequence alignment can be conveniently performed using standard software programs, such as the program NEEDLE implemented in the European Molecular Biology Open Software Suite (EMBOSS), for example, version 6.3.1.2 (Trends in Genetics 16 (6), 276 (2000)), with default parameters such as for protein matrix=EBLOSUM62, gapopen=10.0 and gapextend=0.5.

[0038] The term "stringent conditions" or "hybridization under stringent conditions" refers to conditions under which nucleotide sequences that are sufficiently complementary to each other generally remain hybridized. These stringent conditions are known to those skilled in the art and are described, for example, in Current Protocols in Molecular Biology, John Wiley & Sons, New York (1989) 6.3.1-6.3.6. Based on, for example, Molecular Cloning (Cold Spring Harbor Laboratory, 1989) by Sambrook et al., the skilled person knows how to determine the desired hybridization conditions. In this regard, the term "hybridization conditions" refers not only to the actual conditions during the actual aggregation of nucleic acids, but also to the conditions in the subsequent washing steps. Examples of stringent hybridization conditions are conditions under which, primarily, only those nucleic acid molecules having at least 80%, preferably at least 85%, at least 90%, at least 95%, at least 98% or at least 99% sequence identity hybridize. Stringent hybridization conditions are, for example: 4×SSC at 65° C., and then multiple washes in 0.1×SSC at 65° C. for about 1 hour. The term "stringent hybridization conditions" as used herein may also refer to hybridization in 0.25 M sodium phosphate, pH 7.2, 7% SDS, 1 mM EDTA and 1% BSA at 68° C. for 16 hours, and subsequent washing twice with 2×SSC and 0.1% SDS at 68° C. Preferably, hybridization is performed under stringent conditions.

[0039] The expression "operably linked" means that the elements of the chimeric gene are linked to each other in such a way that their functions are coordinated and allow the expression of the coding sequence, i.e. they are functionally linked. For example, a promoter is functionally linked to another nucleotide sequence when it is able to ensure the transcription and ultimately the expression of the other nucleotide sequence. If two protein encoding nucleotide sequences are linked in such a way that a fusion protein of the first and second protein or polypeptide can be formed, the two proteins are functionally or operably linked to each other.

[0040] When a gene causes an expression product to form, it is said that the gene is expressed. Expression product refers to an intermediate product or end product produced by the transcription and optional translation of a nucleic acid, DNA or RNA (e.g., a second nucleic acid as described herein) encoding this product. During transcription, a DNA sequence controlled by a regulatory region, particularly a promoter, is transcribed into an RNA molecule. When an RNA molecule can be translated into a peptide or protein, it can itself form an expression product or an intermediate product. When the RNA as a gene expression end product, for example, can interact with another nucleic acid or protein, the gene is referred to as an RNA molecule encoding an expression product. The example of an RNA expression product includes inhibitory RNA, such as, for example, sense RNA (co-suppression), antisense RNA, ribozyme, miRNA or siRNA, mRNA, rRNA and tRNA. When the end product of gene expression is a protein or peptide, the gene is referred to as a protein encoding an expression product.

[0041] As used herein, nucleic acid (molecule) or nucleotide (sequence) or polynucleotide refers to both DNA and RNA. DNA also includes cDNA and genomic DNA. Nucleic acid molecules can be single-stranded or double-stranded and can be produced in vitro or even in vivo by chemical synthesis or by biological expression.

[0042] Obviously, whenever the nucleotide sequence of an RNA molecule is defined with reference to the nucleotide sequence of a corresponding DNA molecule, thymine (T) in the nucleotide sequence should be replaced by uracil (U). Whether reference is made to an RNA or DNA molecule will be apparent from the context of the application.

[0043] As used herein, "comprising" and the like should be interpreted as specifying the presence of the features, integers, steps or components mentioned, but not excluding the presence or addition of one or more features, integers, steps or components or combinations thereof. Thus, for example, a nucleic acid or protein comprising a nucleotide or amino acid sequence may comprise more nucleotides or amino acids than the nucleotides or amino acids actually cited, i.e., embedded in a larger nucleic acid or protein. A chimeric gene comprising a functionally or structurally defined DNA region may comprise additional DNA regions, etc.

[0044] Through GRF1, plant cells or other plant precursor tissues with improved regeneration capacity can be provided. This is particularly useful for genetically modified plant cells, especially plant cells with edited genomes.

[0045] According to a preferred embodiment of the present invention, the step (a1) of introducing the at least one nucleotide sequence of interest and GRF1 or the step (a2) of introducing the at least one nucleotide sequence of interest and inducing an enhanced expression level of the endogenous gene encoding GRF1 occurs in the transient transformation of plant cells. For the purposes of the present invention, "transient transformation" means that the inserted sequence is not (stably) integrated into the genome of the plant cell. In another embodiment, a stable transformation is achieved, wherein the nucleotide sequence of interest in steps (a1) and (a2) of the transformation method disclosed herein and / or the polynucleotide encoding the GRF1 polypeptide in step (a1) of the method for modifying the genome disclosed herein is inserted into the genome of the plant cell. According to a particularly preferred embodiment of the present invention, the nucleotide sequence encoding GRF1 is transiently transformed into the cell, while the nucleotide sequence of interest is stably transformed into the genome of the cell.

[0046] Modifying the genome of a plant cell can be achieved by a single-strand DNA break (SSB) or double-strand DNA break (DSB) inducing enzyme or a base editing enzyme, which preferably recognizes a predetermined site in the genome of the cell.

[0047] Therefore, another embodiment of the present invention is a method for modifying the genome of a plant cell, the method comprising the steps of:

[0048] (a1) introducing an expression cassette into a plant cell, the expression cassette comprising a polynucleotide encoding a GRF1 polypeptide, an mRNA (including pre-mRNA) encoding a GRF1 polypeptide, or a GRF1 polypeptide; or

[0049] (a2) inducing enhanced expression levels of an endogenous gene encoding a GRF1 polypeptide in a plant cell; and

[0050] (b) cultivating the plant cell of (a1) or (a2) or a plant cell derived from the plant cell of (a1) or (a2) under the following conditions, wherein in the plant cell, the GRF1 polypeptide is expressed from the expression cassette, the GRF1 polypeptide is translated from the introduced mRNA, the expression of the GRF1 polypeptide from the endogenous gene is enhanced / increased, or preferably, the GRF1 polypeptide is present in an increased amount compared to the amount in a wild-type plant cell or a plant cell into which a polynucleotide encoding a GRF1 polypeptide, an mRNA encoding a GRF1 polypeptide or an expression cassette of a GRF1 polypeptide has not been introduced according to step (a1) or into which an enhanced expression level of an endogenous gene encoding a GRF1 polypeptide has not been induced according to step (a2);

[0051] (c) modifying the genome of the plant cell of (b) by a single-strand DNA break (SSB) or double-strand DNA break (DSB) inducing enzyme or a base editing enzyme, and optionally by a repair nucleic acid molecule, wherein the single-strand DNA break or double-strand DNA break inducing enzyme or the base editing enzyme preferably recognizes a predetermined site in the genome of the cell,

[0052] wherein the modification of the genome at the predetermined site is selected from

[0053] i. substitution of at least one nucleotide;

[0054] ii. a deletion of at least one nucleotide;

[0055] iii. insertion of at least one nucleotide; or

[0056] iv. any combination of i.-iii.; and

[0057] Wherein step (c) is carried out simultaneously with step (a1) / (a2) and / or (b), before step (a1) / (a2), between step (a1) / (a2) and (b), or after step (b).

[0058] As used herein, a "double-stranded DNA break-inducing enzyme" or "DSBI enzyme" is an enzyme that can induce double-stranded DNA breaks at a specific nucleotide sequence (referred to as a "recognition site"). Thus, a "single-stranded DNA or RNA break-inducing enzyme" or "SSBI enzyme" is an enzyme that can induce single-stranded DNA or RNA breaks at a specific nucleotide sequence.

[0059] In order to be able to break at a predetermined target site, the enzyme preferably includes a binding domain and a cleavage domain. Specific enzymes that can induce double or single-strand breaks are nucleases and variants thereof, which no longer contain nuclease functions, but act as recognition molecules combined with another enzyme. In recent years, many suitable nucleases have been developed, particularly tailored endonucleases, including meganucleases, zinc finger nucleases, TALE nucleases, Argonaute nucleases (e.g., derived from Halobacterium glaucoma) and CRISPR nucleases, including, for example, Cas, Cpf1, CasX or CasY nucleases as part of a clustered regularly spaced short palindromic repeat (CRISPR) system. Therefore, in a preferred aspect of the present invention, the DSB or SSB inducing enzyme is selected from a CRISPR system, such as CRISPR / Cas9, CRISPR / Cpf1, CRISPR / CasX, CRISPR / CasY, CRISPR / Csm1 or CRISPR / MAD7a, preferably CRISPR / Cas9 endonuclease or CRISPR / Cpf1 endonuclease, zinc finger nuclease (ZFN), homing endonuclease, large-range nuclease and TAL effector nuclease.

[0060] Rare cutting endonucleases are enzymes with recognition sites preferably about 14 to 70 continuous nucleotides, so even in larger genomes such as most plant genomes, there is also a very low cutting frequency. Homing endonucleases, also referred to as meganucleases, constitute the family of this rare cutting endonucleases. They can be encoded by introns, independent genes or intervening sequences, and present significant structural and functional characteristics, which distinguish them from more classical restriction enzymes, usually distinguished from bacterial restriction modification type II systems. Their recognition sites have general asymmetry, which is completely different from the characteristic dichotomous symmetry of most restriction enzyme recognition sites. It has been shown that several homing endonucleases encoded by introns or inteins promote their respective genetic factors to home to the intron-free or intein-free sites of alleles. By producing site-specific double-strand breaks in intron-free or intein-free alleles, these nucleases produce recombinant gene ends, which participate in gene transformation processes, which replicate coding sequences and cause introns or intervening sequences to be inserted on the DNA level. A list of other rare-cutting meganucleases and their respective recognition sites is provided in Table I (pages 17 to 20) of WO 03 / 004659 (incorporated herein by reference).

[0061] In addition, methods are available for designing custom rare-cutting endonucleases that recognize essentially any target nucleotide sequence of choice. Briefly, chimeric restriction enzymes can be prepared using hybrids between zinc finger domains designed to recognize specific nucleotide sequences and nonspecific DNA cleavage domains from natural restriction enzymes such as Fok1. These methods are described, for example, in WO 03 / 080809, WO 94 / 18313 or WO 95 / 09233, and in Isalan et al. (2001). A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nature biotechnology, 19(7), 656; Liu et al. (1997). Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. Proceedings of the National Academy of Sciences, 94(11), 5525-5530.).

[0062] Another example of a custom designed endonuclease includes TALE nucleases (TALENs), which are based on transcription activator-like effectors (TALEs) from the bacterial genus Xanthomonas fused to the catalytic domain of a nuclease (e.g., FokI or its variants). The DNA binding specificity of these TALEs is defined by repeating variable diresidues (RVDs) of 34 / 35 amino acid repeat units arranged in tandem, such that one RVD specifically recognizes one nucleotide in the target DNA. The repeat units can be assembled to recognize essentially any target sequence and fused to the catalytic domain of a nuclease to produce a sequence-specific endonuclease (see, e.g., Boch et al. (2009). Breaking the code of DNA binding specificity of TAL-type III effectors. Science, 326(5959), 1509-1512; Moscou & Bogdanove (2009). A simple cipher governs DNA recognition by TAL effectors. Science, 326(5959), 1501-1501; and WO 2010 / 079430, WO 2011 / 072246, WO 2011 / 154393, WO 2011 / 146121, WO 2012 / 001527, WO 2012 / 093833, WO WO 2012 / 104729, WO 2012 / 138927, WO 2012 / 138939). WO 2012 / 138927 further describes monomeric (compact) TALENs and TALEs with various catalytic domains and combinations thereof.

[0063] Recently, a new customizable nuclease system has been described; the so-called CRISPR / Cas system. The CRISPR system in its natural environment describes a molecular complex comprising at least one small and separate non-coding RNA (Zetsche et al., "Cpf1Is a Single RNA-Guides Endonuclease of a Class 2CRISPR-Cas System", Cell, 163, pp. 1-13, October 2015) combined with a Cas nuclease or another CRISPR nuclease (such as Cpf1 nuclease), which can produce specific DNA double-strand breaks. Currently, the CRISPR system is divided into 2 categories, which include five types of CRISPR systems, type II systems, for example, use Cas9 as an effector and type V systems use Cpf1 as an effector molecule (Makarova et al., Nature Rev. Microbiol., 2015). In artificial CRISPR systems, synthetic non-coding RNAs and CRISPR nucleases and / or optionally modified CRISPR nucleases (modified to act as nickases or lack any nuclease function) can be used in combination with at least one synthetic or artificial guide RNA or gRNA that binds the functions of crRNA and / or tracrRNA (Makarova et al., 2015, supra). The immune response mediated by CRISPR / Cas in natural systems requires CRISPR-RNA (crRNA), wherein the maturation of this guide RNA that controls the specific activation of CRISPR nucleases varies significantly between the various CRISPR systems characterized to date. First, the invading DNA (also called the spacer) is integrated between two adjacent repeat regions at the proximal end of the CRISPR locus. The type II CRISPR system encodes the Cas9 nuclease as a key enzyme in the interference step, and the system contains both crRNA and trans-activating RNA (tracrRNA) as guide motifs. These hybridize and form a double-stranded (ds) RNA region, which is recognized by RNAseIII and can be cut to form a mature crRNA. These then bind to the Cas molecules to specifically direct the nuclease to the target nucleic acid region. The recombinant gRNA molecules can contain both variable DNA recognition regions and Cas interaction regions, and can therefore be specifically designed, regardless of the specific target nucleic acid and the desired Cas nuclease. As a further safety mechanism, PAM (protospacer sequence adjacent motif) must be present in the target nucleic acid region; these are DNA sequences directly from the DNA recognized by the Cas9 / RNA complex.The PAM sequence of Cas9 from Streptococcus pyogenes has been described as "NGG" or "NAG" (standard IUPAC nucleotide code) (Jinek et al., "A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity", Science 2012, 337: 816-821). The PAM sequence of Cas9 from Staphylococcus aureus is "NNGRRT" or "NNGRR (N)". Further variant CRISPR / Cas9 systems are known. Thus, Neisseria meningitidis Cas9 cuts at the PAM sequence NNNNGATT. Streptococcus thermophilus Cas9 cuts at the PAM sequence NNAGAAW. Recently, an additional PAM motif NNNNRYAC has been described for the CRISPR system of Campylobacter (WO 2016 / 021973 A1). For Cpf1 nuclease, it has been described that, in contrast to the usually G-rich PAM recognized by the Cas9 system, the Cpf1-crRNA complex without tracrRNA effectively recognizes and cuts the target DNA carried out by a short T-rich PAM (Zetsche et al., supra). In addition, by using modified CRISPR polypeptides, specific single-strand breaks can be obtained. The combined use of Cas nickase and various recombinant gRNAs can also induce highly specific DNA double-strand breaks by double DNA nick formation. In addition, by using two gRNAs, the specificity of DNA binding can be optimized, thereby optimizing DNA cutting. At the same time, other CRISPR effectors (such as CasX and CasY effectors) originally described for bacteria are available and represent other effectors that can be used for genome engineering purposes (Burstein et al., "New CRISPR-Cas systems from uncultivated microbes", Nature, 2017, 542, 237-241).

[0064] The cleavage site of the DSBI / SSBI enzyme relates to the exact position of inducing double-strand breaks on DNA or RNA. The cleavage site may or may not be included in the recognition site of the DSBI / SSBI enzyme (overlapping with it), so it is said that the cleavage site of the DSBI / SSBI enzyme is located at or near its recognition site. The recognition site of the DSBI / SSBI enzyme, sometimes also referred to as the binding site, is a nucleotide sequence that is recognized (specifically) by the DSBI / SSBI enzyme and determines its binding specificity. For example, TALEN or ZNF monomers have recognition sites that are determined by their RVD repeats or ZF repeats, respectively, and their cleavage sites are determined by their nuclease domains (e.g., FokI) and are generally located outside the recognition site. In the case of dimeric TALEN or ZFN, the cleavage site is located between the two recognition / binding sites of the corresponding monomer, and the intervening DNA or RNA region where the cleavage occurs is called a spacer.

[0065] One skilled in the art can either select a DSBI / SSBI enzyme that recognizes a certain recognition site and induces DSB or SSB at a cleavage site at or near a preselected / predetermined site, or design such a DSBI / SSBI enzyme. Alternatively, a DSBI / SSBI enzyme recognition site can be introduced into the target genome using any conventional transformation method or by hybridization with an organism having a DSBI / SSBI enzyme recognition site in the genome, and then any desired nucleic acid can be introduced at or near the cleavage site of the DSBI / SSBI enzyme.

[0066] As used herein, a "base editing enzyme" or "base editor" refers to a protein or fragment thereof having the same catalytic activity as the protein from which it is derived, if the base conversion does not cause a silent mutation but rather a conversion of an amino acid encoded by a codon containing the position converted with the base editor, then the protein or fragment thereof alone or when provided as a molecular complex (referred to herein as a base editing complex) has the ability to mediate targeted base modification (i.e., conversion of a target base resulting in a target point mutation), which in turn can result in a targeted mutation. Preferably, at least one base editor according to the present invention is temporarily or permanently connected to at least one site-specific effector, or optionally to a component of at least one site-specific effector complex. The connection can be covalent and / or non-covalent.

[0067] Any base editor or site-specific effector disclosed herein, or a catalytically active fragment thereof, or any component of a base editor complex or a site-specific effector complex can be introduced into a cell as a nucleic acid fragment representing or encoding a DNA, RNA or protein effector, or it can be introduced as DNA, RNA and / or protein, or any combination thereof.

[0068] There are two major and distinct pathways for repairing breaks—homologous recombination and nonhomologous end joining (NHEJ). Homologous recombination requires the presence of a homologous sequence as a template (e.g., a "donor") to direct the cell repair process, and the outcome of the repair is error-free and predictable. In the absence of a template (or "donor") sequence for homologous recombination, cells typically attempt to repair breaks by the process of nonhomologous end joining (NHEJ).

[0069] In the particularly preferred aspect of this embodiment, the repair nucleic acid molecule is additionally introduced into the plant cell.As used herein, "repair nucleic acid molecule" is a single-stranded or double-stranded DNA molecule or RNA molecule, which is used as a template for modifying genomic DNA at the preselected site near the cleavage site or at the cleavage site.As used herein, "template for modifying genomic DNA" refers to that the repair nucleic acid molecule is replicated or integrated at the preselected site by homologous recombination between the corresponding homologous regions flanking the preselected site in the flanking region and the target genome, and is optionally connected to (NHEJ) combination (for example, in the case of only having a flanking region) at one of the two ends of the repair nucleic acid molecule. The integration carried out by homologous recombination will allow the repair nucleic acid molecule to be accurately connected to the target genome until the nucleotide level, and NHEJ can produce a small insertion / deletion at the junction between the repair nucleic acid molecule and the genomic DNA.

[0070] As used herein, "modification of a genome" means that the genome has been altered by at least one nucleotide. This can occur by substitution of at least one nucleotide and / or deletion of at least one nucleotide and / or insertion of at least one nucleotide, as long as it results in a total change of at least one nucleotide compared to the nucleotide sequence of the preselected genomic target site before modification, thereby allowing, for example, identification of the modification by techniques well known to the skilled person (such as sequencing or PCR analysis, etc.).

[0071] As used herein, "preselected site", "predetermined site" or "predefined site" refers to a specific nucleotide sequence in a genome (e.g., a nuclear genome or a chloroplast genome) where one or more nucleotides are desired to be inserted, substituted and / or deleted. This can be, for example, an endogenous locus, or a specific nucleotide sequence located in or connected to a previously introduced exogenous DNA or transgene. A preselected site can be a specific nucleotide position at which (after) insertion of one or more nucleotides is intended. A preselected site can also include a sequence of one or more nucleotides to be exchanged (substituted) or deleted.

[0072] As used in the context of this application, the term "about" refers to + / -10% of the stated value, preferably + / -5% of the stated value. For example, about 100 nucleotides (nt) should be understood as a value between 90 and 110 nt, preferably between 95 and 105.

[0073] As used herein, "flanking region" is a region of a repair nucleic acid molecule having a nucleotide sequence homologous to the nucleotide sequence of a DNA region flanking (i.e., upstream or downstream) a preselected site. Obviously, the length and percentage sequence identity of the flanking region should be selected so that homologous recombination can be performed between the flanking region and their corresponding DNA region upstream or downstream of the preselected site. The DNA region flanking the preselected site that has homology to the flanking DNA region of the repair nucleic acid molecule is also referred to as a homologous region in genomic DNA.

[0074] In order to have enough homology for recombination, the length of the flanking DNA region of the repair nucleic acid molecule can vary, and the length should be at least about 10nt, about 15nt, about 20nt, about 25nt, about 30nt, about 40nt or about 50nt. However, the flanking region can be as long as possible (for example, up to about 100-150kb, such as complete bacterial artificial chromosome (BAC)). Preferably, the flanking region is about 50nt to about 2000nt, for example about 100nt, 200nt, 500nt or 1000nt. In addition, the region of the DNA flank of the target does not need to be identical with the homology region (DNA region flanking the preselected site), and can have about 80% to about 100% sequence identity, preferably about 95% to about 100% sequence identity with the DNA region flanking the preselected site. The longer the flanking region, the less stringent the requirement for homology. Furthermore, in order to exchange the target DNA sequence at the preselected site without changing the DNA sequence of the adjacent DNA sequences, the flanking DNA sequences should preferably be identical to the upstream and downstream DNA regions flanking the preselected site.

[0075] As used herein, "upstream" refers to a position on a nucleic acid molecule that is closer to the 5" end of the nucleic acid molecule. Similarly, the term "downstream" refers to a position on a nucleic acid molecule that is closer to the 3" end of the nucleic acid molecule. For the avoidance of doubt, nucleic acid molecules and their sequences are typically represented in their 5" to 3" orientation (from left to right).

[0076] In order to target sequence modification at a preselected site, the flanking regions must be selected so that the 3" end of the upstream flanking region and / or the 5" end of the downstream flanking region are aligned with the end of the predefined site. Thus, the 3" end of the upstream flanking region determines the 5" end of the predefined site, while the 5" end of the downstream flanking region determines the 3" end of the predefined site.

[0077] As used herein, the preselected site is located outside or away from the cleavage (and / or recognition) site, which means that the site (preselected site) intended for genome modification does not contain a cleavage site and / or recognition site for a DSBI / SSBI enzyme or a base editing enzyme, i.e., the preselected site does not overlap with the cleavage (and / or recognition) site. Therefore, in this regard, outside / away refers to the upstream or downstream of the cleavage (and / or recognition) site.

[0078] Modified plant cells that have been transformed or gene-edited according to the method of the invention and may have a modified genome can be regenerated into complete (fertile) plants. Due to the presence of additional GRF1 in plant cells, their regeneration capacity is significantly improved. Therefore, in a preferred aspect of the present invention, the transformation of plant cells or the modification of the genome of plant cells is followed by a step of regenerating plants, respectively. Therefore, the present invention provides a method for producing transgenic plants, the method comprising:

[0079] (a) transforming a plant cell as described above, and

[0080] (b) regenerating a plant comprising at least one plant cell comprising at least one nucleotide sequence of interest as a transgene from the plant cell of (a) or from a plant cell derived from the plant cell of (a).

[0081] Furthermore, the present invention also provides a method for producing a genetically modified plant, the method comprising:

[0082] (a) modifying the genome of a plant cell as described above, and

[0083] (b) regenerating a plant comprising a modification of the genome in at least one cell or a modified plant cell from the plant cell of (a) or from a plant cell derived from the plant cell of (a).

[0084] As used herein, "regeneration" refers to the process in which single or multiple cells proliferate and develop into tissues, organs, and ultimately entire plants.

[0085] Step b) of regenerating the plant may for example comprise culturing the transformed or genetically modified plant cells from step a) on a regeneration medium.

[0086] Regeneration techniques rely on manipulation of certain plant hormones in tissue culture growth media, and occasionally on biocides and / or herbicide markers that can be introduced with the desired nucleotide sequence of interest. Plant regeneration from cultured protoplasts is described in: Evans et al., Protoplasts Isolation and Culture, Handbook of Plant Cell Culture, pp. 124-176, MacMillilan Publishing Company, New York, 1983; and Binding, Regeneration of Plants, Plant Protoplasts, pp. 21-73, CRC Press, Boca Raton, 1985. Regeneration can also be obtained from plant callus, explants, protoplasts, immature or mature embryos, embryonic tissues, meristems, organs or parts thereof. Such regeneration techniques are generally described in Klee (1987) Ann. Rev. of Plant Phys. 38: 467-486. In order to obtain complete plants from transgenic tissues such as immature embryos, they can be grown under controlled environmental conditions in a series of culture media containing nutrients and hormones, a process known as tissue culture. Once complete plants are produced and seeds are produced, evaluation of the progeny begins.

[0087] According to the present invention, not only the regeneration capacity of transformed or genetically modified plant cells can be improved, but also other types of sensitive cells with poor regeneration capacity can be improved. In particular, the production of haploid plant embryos from precursors such as immature male gametophytes or microspores can be improved by GRF1.

[0088] Therefore, another aspect of the present invention is a method for producing haploid plant embryos, the method comprising the steps of:

[0089] (a1) introducing an expression cassette into an immature male gametophyte or microspore, wherein the expression cassette comprises a polynucleotide encoding a GRF1 polypeptide, an mRNA encoding a GRF1 polypeptide, or a GRF1 polypeptide; or

[0090] (a2) inducing enhanced expression levels of an endogenous gene encoding a GRF1 polypeptide in immature male gametophytes or microspores; and

[0091] (b) cultivating the immature male gametophyte or microspore of (a) under the following conditions, wherein in the immature male gametophyte or microspore, the GRF1 polypeptide is expressed from the expression cassette, the GRF1 polypeptide is translated from the introduced mRNA, the GRF1 polypeptide is enhancedly expressed from the endogenous gene, or preferably, the GRF1 polypeptide is present in an increased amount compared to the amount in a wild-type plant cell or a plant cell into which a polynucleotide encoding a GRF1 polypeptide, an mRNA encoding a GRF1 polypeptide or an expression cassette of a GRF1 polypeptide has not been introduced according to step (a1) or into which enhanced expression level of an endogenous gene encoding a GRF1 polypeptide has not been induced according to step (a2); and

[0092] (c) selecting haploid plant embryos derived from the immature male gametophytes or microspores of step (b).

[0093] The present invention also includes a method for producing haploid seedlings, the method comprising: exposing haploid plant material to a polynucleotide comprising a GRF1 polypeptide, an mRNA encoding a GRF1 polypeptide, or an expression cassette of a GRF1 polypeptide to produce a haploid embryo; and subsequently converting (i.e., germinating) the haploid embryo into a seedling. Therefore, the present invention includes a method for preparing a haploid plant, the method comprising growing the seedling produced according to the above method. The present invention also provides a method for producing a double haploid plant, the method comprising: cultivating a haploid plant material for a period of time in the presence of GRF1; stimulating or allowing spontaneous chromosome doubling; and growing the double haploid plant material into a seedling, a plantlet, or a plant. In certain embodiments, haploid embryogenesis and chromosome doubling may occur substantially simultaneously. In other embodiments, there may be a time delay between haploid embryogenesis and chromosome doubling. If the growth of haploid seedlings, plants, or plantlets does not involve a spontaneous chromosome doubling event, a chemical chromosome doubling agent, such as colchicine, may be used. Many procedures include contacting plant cells with colchicine, an anti-microtubule agent or an anti-microtubule herbicide (such as natrol), nitrous oxide, or any mitotic inhibitor. The result is a homozygous doubled haploid cell. When colchicine is used, the concentration in the culture medium can generally be 0.01%-0.2%. The range of colchicine concentration can be about 400-600 mg / L.

[0094] When the microspores are exposed to the GRF1 polypeptide, callus can then be formed and this can undergo organogenesis to form embryos. Therefore, the present invention includes a method of producing haploid plant callus, the method comprising: exposing immature male gametophytes or microspores to the GRF1 polypeptide or introducing therein an expression cassette comprising a polynucleotide encoding the GRF1 polypeptide, an mRNA encoding the GRF1 polypeptide or a GRF1 polypeptide.

[0095] The immature male gametophytes or microspores are preferably exposed to GRF1 during the culture step for a period of time sufficient to induce haploid embryo formation. The required period of time may depend on the species of plant involved, and these are readily determined by one of ordinary skill in the art. The preferred range for GRF1 exposure is from about 1 to about 20 hours, more preferably from about 2 to about 20 hours.

[0096] In certain aspects of the invention, physical stress is applied to the haploid plant material prior to the introduction of a polynucleotide encoding a GRF1 polypeptide, an mRNA encoding a GRF1 polypeptide, or an expression cassette for a GRF1 polypeptide. The physical stress may be, for example, any of temperature, darkness, light or ionizing radiation, starvation, or osmotic stress. The light may be full spectrum sunlight, or one or more frequencies selected from the visible, infrared, or UV spectrum. The stress may be continuous or intermittent (periodic), regular or random over time.

[0097] In another aspect of the present invention, it was found that the transformation and regeneration capacity of plant materials can be further improved by combining GRF1 and WUS2. Therefore, in addition to introducing a polynucleotide encoding a GRF1 polypeptide, an mRNA encoding a GRF1 polypeptide or an expression cassette of a GRF1 polypeptide as described above in a method for transforming a plant cell, a method for modifying the genome of a plant cell, or a method for producing a haploid plant embryo according to the present invention for step (a1), or inducing an enhanced expression level of an endogenous gene encoding a GRF1 polypeptide as described above in a method for transforming a plant cell, a method for modifying the genome of a plant cell, or a method for producing a haploid plant embryo according to the present invention for step (a2), the method of the present invention according to this aspect further provides for introducing a polynucleotide encoding a WUS2 polypeptide, an mRNA encoding a WUS2 polypeptide or an expression cassette of a WUS2 polypeptide into a plant cell. If in step (a1), an expression cassette comprising a polynucleotide encoding a GRF1 polypeptide is introduced into a cell, the polynucleotide encoding a WUS2 polypeptide may be integrated into the same expression cassette and operably linked to the same regulatory factor.

[0098] The method has proven to be advantageous both in the transformation of plant cells and in the modification of plant cells and in methods for producing transgenic plants, genetically modified plants or haploid plant embryos as described above.

[0099] Preferably, the WUS2 polypeptide of the present invention comprises an amino acid sequence selected from SEQ ID NO: 8, 10, 12, 14, 16, 18, 20, 22 and 24, or an amino acid sequence having at least 70% identity with SEQ ID NO: 8, 10, 12, 14, 16, 18, 20, 22 and 24, preferably at least 80%, at least 85%, at least 90%, more preferably at least 95%, at least 98% or at least 99% identity with SEQ ID NO: 8, 10, 12, 14, 16, 18, 20, 22 and 24.

[0100] The polynucleotide encoding the WUS2 polypeptide of the present invention preferably comprises:

[0101] (i) a coding nucleotide sequence selected from SEQ ID NO: 7, 9, 11, 13, 15, 17, 19, 21 and 23;

[0102] (ii) a coding nucleotide sequence comprising a sequence which is at least 70%, preferably at least 80%, at least 85%, at least 90%, more preferably at least 95%, at least 98% or at least 99% identical to a coding nucleotide sequence selected from the group consisting of SEQ ID NOs: 7, 9, 11, 13, 15, 17, 19, 21 and 23;

[0103] (iii) a nucleotide sequence encoding the WUS2 polypeptide encoded by (i) or (ii) within the degeneracy of the genetic code;

[0104] (iv) a nucleotide sequence complementary to the nucleotide sequence of (i), (ii) or (iii); or / and

[0105] (v) A nucleotide sequence that hybridizes to the nucleotide sequence of (iv) under stringent conditions.

[0106] The present invention is applicable to any plant species, whether monocots or dicots. Preferably, the plant that can be used for the methods and uses of the present invention is a plant selected from the following genus: Hordeum, Sorghum, Saccharum, Zea, Setaria, Oryza, Wheat, Secale, Triticale, Malus, Brachypodium, Aegilops, Daucus, Beta, Eucalyptus, Nicotiana, Solanum, Coffea, Vitis, Erythrante, Utricularia, Cucumis, Morus, Arabidopsis, Mustard, Cardamine, Lepidium, Capsella, Brassica, Brassica, Brassica, Brassica, Arugula, Radish, Citrus, Jatropha, Populus, Medicago, Garbanzo, Pigeon pea, Phaseolus, Glycine, Cotton, Astragalus, Nelumbo, Torenia, Allium or Helianthus. More preferably, the plant is selected from the group consisting of barley, bulbous barley, bicolor sorghum, sugarcane, Zea species including maize, millet, small-grain rice, rice, Australian wild rice, tall wild rice, wheat, durum wheat, rye, triticale, apple, purple Brachypodium, seashore barley, Aegilops tauschii, Australian carrot (Daucus glochidiatus), beet species including beet, baby carrot, carrot (Daucusmuricatus), wild carrot, Eucalyptus grandis, Nicotiana tabacum, Nicotiana velutipes, tobacco, Nicotiana benthamiana, tomato, potato, coffee cane, grape, Erythranthemum truncatum (Erythranthemum glochidiatus), guttata), spiral bladderwort, cucumber, Sichuan mulberry, desert Arabidopsis, deep mountain Arabidopsis, Arabidopsis, Himalayan mustard, egg-leaf mustard, curved cardamine, North American Lepidium, shepherd's purse, incosus, chopstick mustard, European rape, cabbage, turnip, radish, mustard, black mustard, rocket, sweet orange, jatropha, hairy poplar, clover, mountain chickpea, wild chickpea, chickpea, net chickpea, chickpea (Cicer judaicum), pigeon pea, creeper bean, kidney bean, soybean, cotton, astragalus, lotus root, summer pansy, onion, onion, garlic, sunflower, Jerusalem artichoke and / or leek. Particularly preferred are beet, corn, wheat, barley, rye, sunflower, potato, bicolor sorghum, turnip, European rape, mustard, cabbage, radish, rice, soybean and / or cotton.

[0107] Suitable plant cells according to the invention are in particular cells of somatic tissue, callus, meristem or embryonic tissue, or protoplasts, gametophytes, pollen, ovules or microspores. For example, cells of callus, preferably friable callus, meristem, reproductive tissue (e.g., microspores) or embryonic tissue and protoplasts can be used.

[0108] One or more parts of a plant may be attached to or separated from a complete plant. These parts of a plant include, but are not limited to, organs, tissues, and cells of a plant, preferably seeds.

[0109] The subject of the present invention is also a plant obtained or obtainable by the above method. Therefore, one embodiment of the present invention is a transgenic plant obtained or obtainable by the above method for transforming plant cells and regenerating plants from said cells, and its offspring or parts, wherein the offspring or parts contain at least one nucleotide sequence of interest as a transgene. Another embodiment of the present invention is a genetically modified plant obtained or obtainable by the above method for modifying the genome of plant cells and regenerating plants from said cells, and its offspring or parts, wherein the offspring or parts contain the modifications in the genome introduced by the above modification method.

[0110] Another subject of the present invention is a plant cell or seed derived from the above-mentioned transgenic plant or genetically modified plant. This plant cell preferably contains a transiently or stably integrated polynucleotide encoding a GRF1 polypeptide and a single-strand DNA break (SSB) or double-strand DNA break (DSB) inducing enzyme or base editing enzyme that preferably recognizes a predetermined site in the genome of the cell, and optionally contains a repair nucleic acid molecule. The polynucleotide encoding the GRF1 polypeptide is preferably operably linked to a suitable regulatory sequence so that the plant cell can express the GRF1 polypeptide. Regulatory sequences refer to, for example, "promoters", which refer to nucleotide sequences that are usually upstream (5") of their coding sequences, which control the expression of the coding sequence by providing recognition for RNA polymerase and other factors required for correct transcription. "Constitutive promoter" refers to a promoter that directs gene expression in almost all tissues and at all times. Examples of constitutive promoters include CaMV 35S promoter, double CaMV 35S promoter (70S promoter), nopaline synthase (nos) promoter, BdEF1 promoter or ubiquitin promoter such as PcUbi4 or ZmUbi1. "Regulatable promoter" refers to a promoter that directs gene expression not constitutively but in a temporally and / or spatially regulated manner, and includes tissue-specific and inducible promoters. It includes natural and synthetic sequences and sequences that can be a combination of synthetic and natural sequences. Different promoters can direct gene expression in different tissues or cell types, or at different developmental stages, or in response to different environmental conditions. New promoters of various types that can be used in plant cells are constantly being discovered and are well known to those skilled in the art. "Tissue-specific promoter" Refers to a regulated promoter that is not expressed in all plant cells but only in one or more cell types in a specific organ (such as a leaf or seed), a specific tissue (such as an embryo or cotyledon) or a specific cell type (such as a leaf parenchyma cell or a seed storage cell). These promoters also include promoters that are temporarily regulated (such as in early or late embryogenesis) during fruit ripening of developing seeds or fruits, in fully differentiated leaves, or at the beginning of senescence. "Inducible promoter" refers to those regulated promoters that can be turned on in one or more cell types by external stimuli (such as chemicals, light, hormones, stress or pathogens). Examples of inducible promoters are promoters induced by ecdysone, dexamethasone, and ethanol.Such promoters are well known in the art (e.g., Samalova et al. (2005). pOp6 / LhGR: a stringently regulated and highly responsive dexamethasone-inducible gene expression system for tobacco, The Plant Journal, 41(6), 919-935; Gatz & Lenk (1998). Promoters that respond to chemical inducers, Trends in Plant Science, 3(9), 352-358.).

[0111] Another subject of the present invention is a haploid plant embryo obtained or obtainable by the method according to the invention.

[0112] Another subject of the present invention is a plant cell comprising a transiently or stably integrated polynucleotide encoding a GRF1 polypeptide and a single-strand DNA break (SSB) or double-strand DNA break (DSB) inducing enzyme or base editing enzyme that preferably recognizes a predetermined site in the genome of the cell, and optionally comprises a repair nucleic acid molecule, wherein preferably, the polynucleotide encoding the GRF1 polypeptide is operably linked to a suitable regulatory sequence, so that the plant cell is able to express the GRF1 polypeptide. Such a plant cell can be obtained when the above-mentioned method for modifying the genome of a plant cell is performed.

[0113] Another aspect of the present invention is the use of a polynucleotide encoding a GRF1 polypeptide, an mRNA encoding a GRF1 polypeptide, a GRF1 polypeptide or an activator of expression of an endogenous gene encoding a GRF1 polypeptide in a method for transforming plant cells, preferably in a method for modifying a genome as described above, in a method for producing a plant or a haploid plant embryo, preferably in a method for producing a plant or a haploid plant embryo as described above, or in a method for regenerating a plant, preferably in a method for regenerating a plant as described above. According to a preferred aspect, the use is combined with a polynucleotide encoding a WUS2 polypeptide, an mRNA encoding a WUS2 polypeptide or a WUS2 polypeptide.

[0114] Unless otherwise stated in the examples, all recombinant DNA techniques are performed according to standard protocols, such as described in: Sambrook et al. (1989), Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor Laboratory Press, New York, and Ausubel et al. (1994) Current Protocols in Molecular Biology, Current Protocols, Volumes 1 and 2, USA. Standard materials and methods for plant molecular work are described in RDD Ray's Plant Molecular Biology Labfax (1993), which is jointly published by BIOS Scientific Publishing Co., Ltd. (UK) and Blackwell Scientific Publications, UK. Other references to standard molecular biology techniques include Sambrook and Russell (2001) Molecular Cloning: A Laboratory Manual, Third Edition, Cold Spring Harbor Laboratory Press, New York, and Brown (1998) Molecular Biology LabFax, Volumes I and II, Second Edition, Academic Press (UK). Standard materials and methods for polymerase chain reaction can be found in: Dieffenbach and Dveksler (1995) PCR Primer: A Laboratory Manual, Cold Spring Harbor Laboratory Press and McPherson et al. (2000) PCR-Basics: From Background to Bench, 1st edition, Springer-Verlag, Germany.

[0115] All patents, patent applications, and publications or published disclosures (including publications on the Internet) mentioned or cited herein are incorporated by reference in their entirety.

[0116] The present invention will be further described with reference to the following figures and examples described herein. However, it should be understood that the present invention is not limited to these examples.

[0117] Attached photos

[0118] Figure 1 , Evaluation of biolistic delivery by tDT expression (24 hours after bombardment). A and C: Immature embryos bombarded with tDT constructs; A, RFP channel and C, bright field; B and D: Immature embryos bombarded with three constructs: ZmWUS2, ZmBBM and tDT; B, RFP channel and D, bright field.

[0119] Figure 2. Evaluation of biolistic delivery by target gene expression: A: tDT gene is expressed in samples bombarded with tDT constructs, but not in wild-type A188 embryos; B: ZmWUS2 gene is expressed in samples bombarded with ZmWUS2 constructs, but not in wild-type A188 embryos or samples bombarded with tDT constructs alone; C: ZmBBM gene is expressed in samples bombarded with ZmBBM constructs, but not in wild-type A188 embryos or samples bombarded with tDT constructs alone.

[0120] Figure 3. ZmGRF1 expression is upregulated in ZmWUS2 and ZmBBM expressing samples. A: ZmGRF1 expression is higher in samples bombarded with WUS2 / BBM / tDT compared to samples bombarded with tDT alone; B and C: ZmGRF1 expression is significantly increased in transgenic WUS / BBM callus samples (B) and shoots (C) compared to tDT controls obtained from Agrobacterium transformation.

[0121] Figure 4. Transient delivery of ZmGRF1 enhances regeneration. Fluorescent embryonic structures appeared 1 month after bombardment in tDT-only samples (A), ZmWUS2 / ZmGRF1 / tDT samples (B), and ZmWUS2 / ZmPLT7 / tDT (C).

[0122] Figure 5 , Figure 4 Quantification of fluorescent embryo structures.

[0123] Figure 6 , A188 maize line. Transformation frequency fold change comparing ZmGRF1 to standard transformation construct. In experiment 1 (left column), due to the growth of the event, transgenic plants were obtained 3 weeks earlier than in the standard transformation.

[0124] Figure 7 , Increase in transformation frequency in stable transformation of A188 maize line. Number and size of events after callus selection. Standard construct (left) ZmGRF1 (right)

[0125] Figure 8 , Increase in transformation frequency in stable transformation of A188 maize line. ZmGRF1 overexpressing single copy lines in GH have no phenotype (left) and they are fertile (right)

[0126] Fig. 9 Effect of co-transformation of GRF1 on transformation efficiency Standard Agrobacterium-mediated transformation of two constructs (A and B) was compared with co-transformation using Agrobacterium containing a binary vector expressing GRF1.

[0127] Fig.10、The vector map of pAMK-BdUbi10-ZmBbm

[0128] Fig.11 , vector map of pAMK-BdEF1-ZmWus2

[0129] Fig.12 , vector map of pAMK-BdEF1-ZmGRF1

[0130] Fig.13 、The vector map of pLH-Pat5077399-70Subi-tDT Example

[0131] 1. Biolistic delivery:

[0132] Gene cloning and construct preparation

[0133] Maize PLT7 (ZmPLT7; cDNA = SEQ ID NO: 4; protein = SEQ ID NO: 5), BBM (ZmBBM; cDNA = SEQ ID NO: 6; protein = SEQ ID NO: 7), WUS2 (ZmWUS2; cDNA = SEQ ID NO: 8; protein = SEQ ID NO: 9), and GRF1 (ZmGRF1; genomic DNA = SEQ ID NO: 1; cDNA = SEQ ID NO: 2; protein = SEQ ID NO: 3) genes were cloned by RT-PCR using total RNA isolated from maize A188 immature embryos. The enhanced gene fragments were cloned into the expression vector pAMK-BdUbil0 or pAMK-BdEF1 at the cloning site and expressed under the control of the BdUbil0 promoter or the BdEF1 promoter. Both promoters are strong constitutive promoters from Brachypodium. Figures 10 to 12 Diagrams of sequencing-confirmed constructs are shown.

[0134] Preparation of maize immature embryos for bombardment

[0135] 9-12 days after pollination, harvest the immature embryo size of corn cobs of 0.8 to 1.8 mm, preferably 1.0-1.5 mm. Sterilize the corn cobs with 70% ethanol for 10-15 minutes. After short air drying in a laminar flow hood, remove the top ~ 1 / 3 of the kernel from the corn cob with a shark scalpel, and carefully pull the immature embryo out of the kernel with a spatula. The freshly separated embryos are placed on the bombardment target area in the osmotic culture medium plate (see below), with the scutellum side facing up. Wrap the plate with parafilm and cultivate 4 hours at 25°C in the dark before bombardment.

[0136] Particle co-bombardment

[0137] Use particle bombardment gun and gold particles of size 0.4 or 0.6 micron (μm) to deliver DNA to the scutellum cells of maize immature embryos. Premix plasmid with gene of interest (GOI). For 10 shots, a total volume of 100 microliters (μl) of 50% (v / v) glycerol 1mg gold particles (100 μg gold particles per injection) was pipetted into a transparent low retention microcentrifuge tube. Ultrasonic treatment was performed for 15 seconds to suspend the gold particles. While vortexing at low speed, the following items were added in order to each 100 μl gold particles:

[0138] -—Maximum 10 μl DNA (premix 1.0-10.0 μg total DNA, 100-1000 ng per bombardment)

[0139] -100 μl 2.5M CaCl2 (pre-chilled on ice)

[0140] -40 μl 0.1 M cold spermidine

[0141] The gold particles of DNA coating are vortexed for 2-30 minutes at 0-10 ℃. After washing twice in 500 μ l 100% ethanol, the precipitate is resuspended in 120 μ l 100% ethanol. While the low-speed vortex, the gold particles of 10 μ l are evenly pipetted to the center of the macrocarrier from the tube with the 20 μ l tips of wide opening, because the particle is easy to form agglomerates at this time, therefore the gold particles are arrived on the macrocarrier as soon as possible. Air drying. Use Bio-Rad PDS-1000 / He particle gun to bombard. Bombardment conditions are: 28mm / Hg vacuum, 450 or 650psi rupture disk, 6mm gap distance, the second position of the sample platform at the bottom 60mm distance in the room, and each sample (maize immature embryo) flat plate is injected three times.

[0142] Post-bombardment observation and embryo culture

[0143] After bombardment, embryos were maintained on the osmotic medium for another 16 hours. 16-20 hours after bombardment, tDT expression of transient conversion was checked using a fluorescence microscope with maximum excitation 554nm and maximum emission 581nm. Embryos with dense fluorescent signals under a fluorescence microscope were selected and transferred from N6OSM to N6-5Ag flat plates (about 15 embryos per flat plate) (wherein the scutellum faces upward) for callus induction.

[0144] Osmotic medium: N6 salts, N6 vitamins, 1.0 mg / L 2,4-D, 100 mg / L casein, 0.7 g / L L-proline, 0.2 M mannitol (36.4 g / L), 0.2 M sorbitol (36.4 g / L), 20 g / L sucrose, 15 g / L bacterial culture agar, pH 5.8.

[0145] N6-5Ag: N6 salts, N6 vitamins, 1.0 mg / L 2,4-D, 100 mg / L casein, 2.9 g / L L-proline, 20 g / L sucrose, 5 g / L glucose, 5 mg / L AgNO3, 8 g / L bacterial culture agar, pH 5.8.

[0146] 2. Identification of ZmWUS2 and ZmBBM targets:

[0147] The following constructs were used in biolistic delivery of A188 immature embryos: pAMK-BdUbi10Zm-Bbm, pAMK-BdEF1ZmWus2, pLH-Pat5077399-70Subi-tDt

[0148] The experimental setup is as follows:

[0149]

[0150] The success of plasmid delivery was assessed by tDT expression 24 hours after biolistic delivery. Figure 1 This indicates that the bombardment was successful for categories 2 and 3. Furthermore, the expression of the introduced genes tDT, ZmWUS2, and ZmBBM (category 3) was measured ( FIG. 2 ).

[0151] 3. RNAseq analysis:

[0152] 24 hours after biolistic delivery, immature embryos were collected and snap frozen in liquid nitrogen. All samples were subsequently sent for RNA extraction, library preparation, and RNAseq, which was performed by an external sequencing provider.

[0153] Several candidates were identified by comparison between samples containing only tDT (category 2) and samples containing ZmWUS2, ZmBBM and tDT (category 3). Sixteen genes showed upregulated expression in response to expression of ZmWUS2 and ZmBBM, and five genes showed downregulated expression. After confirmation by qRT-PCR, the candidate ZmGRF1 was selected for further analysis. Figure 3AIt was shown that ZmGRF1 expression was higher in samples bombarded with constructs containing ZmWUS2, ZmBBM and TDt (category 3). In addition, ZmWUS2 and ZmBBM were stably integrated by Agrobacterium-mediated transformation. The expression of ZmGRF1 was evaluated in callus samples and shoots of maize plants. The expression of ZmGRF1 was significantly increased in WUS2 / BBM overexpressing plant material compared to the control obtained by Agrobacterium transformation of tDT gene only ( Figure 3B and Figure C).

[0154] 4. Transient assay for testing ZmGRF1

[0155] A188 immature embryos were bombarded with the following constructs:

[0156]

[0157] One month after bombardment, the fluorescent embryonic structures were counted. This structure indicates enhanced regeneration capacity. Samples transiently transformed with tDT alone showed less obvious embryonic structures (category 1; Figure 4A ). According to the combination of ZmWUS2 and ZmPLT7, it is known that an enhancement of regeneration can be achieved. Therefore, this category 3 was used as a positive control ( Figure 4C Even more impressively, the appearance of fluorescent embryonic structures in samples transiently expressing ZmWUS2 and ZmGRF1 as well as tDT (category 2) was more pronounced than in the positive control ( Figure 4B Quantitation confirmed the visual results and showed that the percentage of fluorescent embryonic structures in samples transiently expressing ZmWUS2 and ZmGRF1 and tDT (category 2) was more than 5-fold higher than in category 1 and more than 2-fold higher than in category 3 ( Figure 5 ).

[0158] 5. Corn transformation method

[0159] According to standard protocols (Ishida Y, Saito H, Ohta S, Hiei Y, Komari T, Kumashiro T (1996) High efficiency transformation of maize (Zea mays L.) mediated by Agrobacterium tumefaciens Nat Biotechnol 14: 745-750), maize transformation (strain A188) was performed using Agrobacterium. In brief, immature embryos of the A188 strain were inoculated with Agrobacterium and co-cultivated for 7 days. After the initial embryonic callus was produced, a selection medium was used in which herbicides were selected for the transformation event. The DNA of the presumed transgenic plants was extracted and the presence of selectable marker genes was analyzed by qPCR. The transformation efficiency was calculated as the number of transgenic events (%) for each inoculated embryo. When co-transformation was performed, equal amounts of Agrobacterium containing constructs and the GRF1 gene were mixed together before inoculation.

[0160] The results showed that up to 4 times higher transformation efficiency was achieved compared to standard transformation, ie without additional delivery of ZmGRF1. In addition, it was advantageous that transgenic plants were obtained approximately 3 weeks earlier due to the rapid growth of the event. Figure 6 Quantitative analysis of two independent experiments is shown. Figure 7 A visual comparison is shown. Corn plant lines with a single copy event of ZmGRF1 grown in a greenhouse had no undesirable phenotypes and were fertile ( Figure 8 ).

[0161] Furthermore, the effect of co-transformation with GRF1 on transformation efficiency was investigated. Standard Agrobacterium-mediated transformation of two constructs (A and B) was compared with co-transformation with Agrobacterium containing a binary vector expressing GRF1. When GRF1 was used, transformation efficiency was 2.3 and 1.8 times higher ( Fig. 9 ). In addition, the co-transformation experiment was 36% faster than the standard protocol.

Claims

1. A method for transforming plant cells, comprising the following steps: (a) Parallel or sequential introduction into plant cells i. at least one nucleotide sequence of interest; and ii. an expression cassette comprising a polynucleotide encoding a GRF1 polypeptide, an mRNA encoding a GRF1 polypeptide, or a GRF1 polypeptide; and (b) Optionally, cultivating the plant cell of (a) or a plant cell derived from the plant cell of (a) under the following conditions: wherein in the plant cell, the GRF1 polypeptide is expressed from the expression cassette, the GRF1 polypeptide is translated from the introduced mRNA, the GRF1 polypeptide is enhancedly expressed from an endogenous gene, or the GRF1 polypeptide is present.

2. A method for producing a transgenic plant, comprising the following steps: (a) transforming a plant cell according to the method of claim 1, and (b) regenerating a plant comprising at least one cell comprising at least one nucleotide sequence of interest as a transgene from the plant cell of (a) or from a plant cell derived from the plant cell of (a).

3. A method for producing haploid plant embryos, comprising the following steps: (a) introducing an expression cassette comprising a polynucleotide encoding a GRF1 polypeptide, mRNA encoding a GRF1 polypeptide, or a GRF1 polypeptide into an immature male gametophyte or microspore; (b) cultivating the immature male gametophyte or microspore of (a) under the following conditions: wherein in the immature male gametophyte or the microspore, the GRF1 polypeptide is expressed from the expression cassette, the GRF1 polypeptide is translated from the introduced mRNA, the GRF1 polypeptide is enhanced to be expressed from an endogenous gene, or the GRF1 polypeptide is present; as well as (c) selecting haploid plant embryos derived from the immature male gametophyte of step (b) or the microspores.

4. The method of any one of claims 1 to 3, wherein the GRF1 polypeptide comprises a PFAM domain PF08880 and a PFAM domain PF08879, preferably wherein the PFAM domain PF08880 finds at least 90% coverage of a match at or near the N-terminus of the GRF1 polypeptide, and the PFAM domain PF08879 finds at least 90% coverage of a match at the C-terminus of the PFAM domain PF08880 located in the GRF1 polypeptide.

5. The method of claim 4, wherein both matching stretches of amino acids are located in the N-terminal half of the GRF1 polypeptide.

6. The method of any one of claims 1 to 5, wherein the GRF1 polypeptide comprises the motif [D]-[P]-[E]-[P]-[G]-[R]-[C]-[R]-[R]-[T]-[D]-[G]-[K]-[K]-[W]-[R]-[C]-[AS]-[RK]-[ED]-[A]-[AH]-[PQS]-[D]-[S]-[K]-[Y]-[C]-[E]-[KR]-[H]-[M]-[H]-[R]-[G]-[R]-[N]-[R] (SEQ ID NO:25), with a maximum of two mismatches, wherein preferably the motif consists of any one of the amino acid sequences SEQ ID NO:26 to SEQ ID NO:35, and / or wherein preferably the motif contains a sub-region that matches the amino acid stretch of the PFAM domain PF08879.

7. The method of any one of claims 1 to 6, wherein the GRF1 polypeptide comprises: (i) an amino acid sequence selected from the group consisting of SEQ ID NO: 2, 37, 39, 41, 43, 45, 47, 49, 51 and 53; or (ii) an amino acid sequence comprising a sequence that is at least 70% identical to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 37, 39, 41, 43, 45, 47, 49, 51 and 53.

8. The method of any one of claims 1 to 7, wherein the polynucleotide encoding the GRF1 polypeptide comprises: (i) an encoding nucleotide sequence selected from SEQ ID NO: 1, 36, 38, 40, 42, 44, 46, 48, 50 and 52; (ii) a coding nucleotide sequence comprising a sequence that is at least 70% identical to a nucleotide sequence selected from the group consisting of SEQ ID NOs: 1, 36, 38, 40, 42, 44, 46, 48, 50 and 52; (iii) a nucleotide sequence encoding the polypeptide encoded by (i) or (ii) within the degeneracy of the genetic code; (iv) a nucleotide sequence complementary to the nucleotide sequence of (i), (ii) or (iii); or (v) A nucleotide sequence that hybridizes to the nucleotide sequence of (iv) under stringent conditions.

9. The method of any one of claims 1 to 8, wherein the introduction of an expression cassette comprising a polynucleotide encoding a GRF1 polypeptide into a plant cell results in its stable integration into the genome of the plant cell, or wherein the introduction of an expression cassette comprising a polynucleotide encoding a GRF1 polypeptide, an mRNA encoding a GRF1 polypeptide or a GRF1 polypeptide into a plant cell or the induction of an enhanced expression level of an endogenous gene encoding a GRF1 polypeptide in a plant cell results in the transient appearance of the GRF1 polypeptide in the plant cell or in a progeny cell thereof.

10. The method of any one of claims 1 to 9, wherein said polynucleotide encoding said GRF1 polypeptide is operably linked to at least one regulatory sequence suitable for expressing said GRF1 polypeptide in a plant cell.

11. The method of any one of claims 1 to 2, wherein the plant cell of step (a) is a cell of somatic tissue, callus tissue, meristem or embryonic tissue, protoplast, gametophyte, pollen, ovule or microspore.

12. A plant or part thereof or progeny plant thereof obtained or obtainable by the method of claim 2.

13. A plant cell or seed of the plant of claim 12, wherein said plant cell or said seed comprises said at least one nucleotide sequence of interest as a transgene or comprises said modification in the genome.

Citation Information

Patent Citations

  • Regulated gene expression in plants

    US20020046419A1

  • Functional domains in flavobacterium okeanokoites (FOKI) restriction endonuclease

    WO1994018313A1

  • Functional domains in flavobacterium okeanokoites (FOKI) restriction endonuclease

    WO1995009233A1

  • Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms

    WO2003004659A2

  • Methods and compositions for using zinc finger endonucleases to enhance homologous recombination

    WO2003080809A2